Skip to main content

Table 3 Incidence of diarrhea after first- and second-line weekly irinotecan and capecitabine

From: Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients

  Total Grade I Grade II Grade III Grade IV
   Number (%) Number (%) Number (%) Number (%)
First-line treatment 30 (57.7) 10 (33.3) 3 (10) 2 (6.7) 0 (0)
Second-line treatment 22 (42.3) 6 (27.3) 2 (9.1) 1 (4.5) 1 (4.5)